http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102727633-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02898911a9c79256ee95420e73ffecfd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752 |
| filingDate | 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0141b39761cc806afd4e94fff890f01a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73df75c0fedb07f0a7408475b6d7115e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e364b50c0ffdd18e297df018a03ddc1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499fc3a9729416d124e8ab543c21ea2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_353bea9e6b575ad7ffd78f52fb6ef4eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d01826b3d3d94055b7f3fb52b448209 |
| publicationDate | 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102727633-B |
| titleOfInvention | Pharmaceutical composition for treating chronic hepatitis B and preparation method and application thereof |
| abstract | The invention discloses a pharmaceutical composition for treating chronic hepatitis B, which is a preparation prepared by raw material drugs according to the following weight ratios: 14-26 parts of immature bitter orange, 8-16 parts of bupleurum chinense, 7-13 parts of peach kernel, 7-13 parts of salvia miltiorrhiza, 10-20 parts of giant knotweed rhizome, 7-13 parts of root of herbaceous peony, 7-13 parts of rhizoma atractylodis macrocephalae, and 7-13 parts of poria cocos. The invention also provides a preparation method and an application of the pharmaceutical composition. The clinical study finds that the pharmaceutical composition can obviously improve clinical symptoms, liver function and HBV-DNA (hepatitis B virus-deoxyribonucleic acid) of liver-stagnation with spleen-deficiency type chronic hepatitis B, and has good effects of protecting liver and lowering transaminase and anti-HBV activity, thus providing a new choice for the clinical medication for treating the chronic hepatitis B. |
| priorityDate | 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.